140 related articles for article (PubMed ID: 37431065)
1. Phase I evaluation of CycloSam
Selting KA; Simon J; Lattimer JC; Ketring A; Axiak-Bechtel S; Frank K; Wendt RE; Bryan JN; Tate D; Maitz C; Lunceford J; Donnelly L; Keegan K; Henry CJ
Vet Radiol Ultrasound; 2023 Sep; 64(5):982-991. PubMed ID: 37431065
[No Abstract] [Full Text] [Related]
2. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
Anderson PM; Wiseman GA; Dispenzieri A; Arndt CA; Hartmann LC; Smithson WA; Mullan BP; Bruland OS
J Clin Oncol; 2002 Jan; 20(1):189-96. PubMed ID: 11773169
[TBL] [Abstract][Full Text] [Related]
3. Targeted radiotherapy with Sm-153-EDTMP in nine cases of canine primary bone tumours.
Milner RJ; Dormehl I; Louw WK; Croft S
J S Afr Vet Assoc; 1998 Mar; 69(1):12-7. PubMed ID: 9646255
[TBL] [Abstract][Full Text] [Related]
4. The use of fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography as an effective method for staging in dogs with primary appendicular osteosarcoma.
Crooks C; Randall E; Griffin L
Vet Radiol Ultrasound; 2021 May; 62(3):350-359. PubMed ID: 33629412
[TBL] [Abstract][Full Text] [Related]
5. Comparison of systemic toxicities of 177Lu-DOTMP and 153Sm-EDTMP administered intravenously at equivalent skeletal doses to normal dogs.
Bryan JN; Bommarito D; Kim DY; Berent LM; Bryan ME; Lattimer JC; Henry CJ; Engelbrecht H; Ketring A; Cutler C
J Nucl Med Technol; 2009 Mar; 37(1):45-52. PubMed ID: 19223431
[TBL] [Abstract][Full Text] [Related]
6. Staging canine patients with appendicular osteosarcoma utilizing fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography.
Brody A; Crooks JC; French JM; Lang LG; Randall EK; Griffin LR
Vet Comp Oncol; 2022 Sep; 20(3):541-550. PubMed ID: 35166445
[TBL] [Abstract][Full Text] [Related]
7. Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma.
Loeb DM; Garrett-Mayer E; Hobbs RF; Prideaux AR; Sgouros G; Shokek O; Wharam MD; Scott T; Schwartz CL
Cancer; 2009 Jun; 115(11):2514-22. PubMed ID: 19338063
[TBL] [Abstract][Full Text] [Related]
8. Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain.
Fan TM; de Lorimier LP; O'Dell-Anderson K; Lacoste HI; Charney SC
J Vet Intern Med; 2007; 21(3):431-9. PubMed ID: 17552447
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of fluorine
Griffin LR; Thamm DH; Brody A; Selmic LE
J Vet Intern Med; 2019 Mar; 33(2):820-826. PubMed ID: 30768736
[TBL] [Abstract][Full Text] [Related]
10. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006).
Bacon NJ; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
J Am Vet Med Assoc; 2008 May; 232(10):1504-10. PubMed ID: 18479240
[TBL] [Abstract][Full Text] [Related]
11. Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer.
Autio KA; Pandit-Taskar N; Carrasquillo JA; Stephenson RD; Slovin SF; Rathkopf DE; Hong C; Heller G; Scher HI; Larson SM; Morris MJ
Cancer; 2013 Sep; 119(17):3186-94. PubMed ID: 23765638
[TBL] [Abstract][Full Text] [Related]
12. Intramedullary cisplatin chemotherapy: experience in four dogs with osteosarcoma.
Hahn KA; Richardson RC; Blevins WE; Lenz SD; Knapp DW
J Small Anim Pract; 1996 Apr; 37(4):187-92. PubMed ID: 8731408
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of use of fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography (
Slinkard PT; Randall EK; Griffin LR
Can J Vet Res; 2021 Apr; 85(2):131-136. PubMed ID: 33883821
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.
Skorupski KA; Uhl JM; Szivek A; Allstadt Frazier SD; Rebhun RB; Rodriguez CO
Vet Comp Oncol; 2016 Mar; 14(1):81-7. PubMed ID: 24118677
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma.
Story AL; Boston SE; Kilkenny JJ; Singh A; Woods JP; Culp WTN; Skorupski KA; Lu X
J Vet Intern Med; 2017 Jul; 31(4):1159-1162. PubMed ID: 28503759
[TBL] [Abstract][Full Text] [Related]
17. Samarium Sm 153 lexidronam for the palliative treatment of dogs with primary bone tumors: 35 cases (1999-2005).
Barnard SM; Zuber RM; Moore AS
J Am Vet Med Assoc; 2007 Jun; 230(12):1877-81. PubMed ID: 17571994
[TBL] [Abstract][Full Text] [Related]
18. A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical.
Simón J; Frank RK; Crump DK; Erwin WD; Ueno NT; Wendt RE
Nucl Med Biol; 2012 Aug; 39(6):770-6. PubMed ID: 22459336
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy.
Matsuyama A; Schott CR; Wood GA; Richardson D; Woods JP; Mutsaers AJ
J Am Vet Med Assoc; 2018 Jun; 252(11):1377-1383. PubMed ID: 29772973
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid for the treatment of appendicular osteosarcoma in a dog.
Spugnini EP; Vincenzi B; Caruso G; Baldi A; Citro G; Santini D; Tonini G
J Small Anim Pract; 2009 Jan; 50(1):44-6. PubMed ID: 18793253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
